PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRα-induced myeloproliferative disease.
Cools J, Stover EH, Boulton CL, Gotlib J, Legare RD, Amaral SM, Curley DP, Duclos N, Rowan R, Kutok JL, Lee BH, Williams IR, Coutre SE, Stone RM, DeAngelo DJ, Marynen P, Manley PW, Meyer T, Fabbro D, Neuberg D, Weisberg E, Griffin JD, Gilliland DG.
Cools J, et al. Among authors: lee bh.
Cancer Cell. 2003 May;3(5):459-69. doi: 10.1016/s1535-6108(03)00108-9.
Cancer Cell. 2003.
PMID: 12781364
Free article.